NERV
Minerva Neurosciences Inc
3.30$
+1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | |
| – | +0.0% | 0.0% | +0.0% | -27.5% | +275.7% | +0.0% | -93.6% | +0.1% | -0.1% | – | – | – | |
| – | – | – | – | – | – | +0.0% | -106.4% | – | – | – | – | – | |
| – | +37.1% | -11.7% | -7.4% | -51.1% | +5.0% | -31.3% | -4.7% | -28.7% | +134.9% | +241,661.4% | -99.9% | – | |
| – | -7.0% | +2.6% | -3.9% | +2.6% | +2.4% | +0.0% | -18.3% | -7.6% | +46.3% | +406,477.6% | -100.0% | – | |
| – | +18.0% | -6.8% | -6.1% | -30.4% | +3.6% | -13.7% | -13.5% | -15.7% | +75.1% | +234.7% | -36.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.0% | +2.8% | +2.7% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -119.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -140,550.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -119.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -119.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.